Skip to main navigation
Ra Pharma
Ra Pharma
  • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Zilucoplan (RA101495 SC)
    • Preclinical & Discovery
    • Therapeutic Areas
    • Clinical Trials
  • Our Science
    • Extreme Diversity™ Platform
    • Partnership
    • Presentations and Publications
  • For Patients
    • gMG
  • For HCPs
    • gMG
  • News & Investors
    • Overview
    • News & Events
      • News Releases
      • Event Calendar
    • Presentations and Publications
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
    • Investor FAQ
    • Contact Us
  • Working at Ra
  • Contact Us
  • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Zilucoplan (RA101495 SC)
    • Preclinical & Discovery
    • Therapeutic Areas
    • Clinical Trials
  • Our Science
    • Extreme Diversity™ Platform
    • Partnership
    • Presentations and Publications
  • For Patients
    • gMG
  • For HCPs
    • gMG
  • News & Investors
    • Overview
    • News & Events
      • News Releases
      • Event Calendar
    • Presentations and Publications
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
    • Investor FAQ
    • Contact Us
  • Working at Ra
  • Contact Us
  • News & Investors

Overview

News & Events

News Releases

Event Calendar

Presentations and Publications

Stock Information

Stock Quote & Chart

Historical Price Lookup

Investment Calculator

SEC Filings

Corporate Governance

Documents & Charters

Management

Board of Directors

Committee Composition

Investor FAQ

Contact Us

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
Sep 30, 2016 S-1

Registration statement for face-amount certificate companies

Registration Statements
0001047469-16-015866.rtf
0001047469-16-015866.xls
0001047469-16-015866.pdf
Jul 23, 2015 D
Other
0001481512-15-000002.rtf
0001481512-15-000002.pdf
Feb 24, 2010 D
Other
0001481512-10-000001.rtf
0001481512-10-000001.pdf

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Current page 22

Copyright Morningstar

  • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Zilucoplan
    • Preclinical & Discovery
    • Therapeutic Areas
    • Clinical Trials
  • Our Science
    • Extreme Diversity™ Platform
    • Partnership
    • Presentations and Publications
  • For Patients
    • Overview
    • gMG
    • IMNM
  • For HCPs
    • Overview
    • gMG
    • IMNM
  • News & Investors
    • News & Events
    • Presentations and Publications
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQ
  • Working at Ra
    • Our Work Philosophy
    • Open Positions
  • Contact Us
Ra Twitter Ra LinkedIn
Developed by Synergy Networx     © 2019 Ra Pharmaceuticals, Inc. All rights reserved. | Terms & Conditions